For research use only. Not for therapeutic Use.
Dextromilnacipran (F2696; (1R,2S)-milnacipran), an enantiomer of milnacipran, is a selective serotonin and norepinephrine (5-HT/NE) reuptake inhibitor. Dextromilnacipran also is a human alpha-adrenergic receptor antagonist, with an IC50 of 3.4 μM. (patent WO2013014263A1).
| Catalog Number | I012513 |
| CAS Number | 96847-55-1 |
| Synonyms | (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide |
| Molecular Formula | C15H22N2O |
| Purity | ≥95% |
| InChI | InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m1/s1 |
| InChIKey | GJJFMKBJSRMPLA-HIFRSBDPSA-N |
| SMILES | CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2 |
| Reference | [1]. Pierre Sokoloff. Levomilnacipran drug for functional rehabilitation after an acute neurological stroke. WO2013014263A1. |
